Skip to main content
NextGen MedPrep logoNextGenMedPrep
Back to Medical School Compare
Medical school comparison

Barts and The London (Queen Mary) vs University of Central Lancashire (UCLan)

Barts and The London (Queen Mary) and University of Central Lancashire (UCLan) are both UK medical schools, but the path to an offer at each is meaningfully different. Barts and The London (Queen Mary) is based in London (London) while University of Central Lancashire (UCLan) sits in Preston (England), and the regional context shapes everything from fee status to NHS-deanery destination. Their A-Level requirements (A*AA vs AAB) place them in slightly different academic-strictness tiers. Barts and The London (Queen Mary) is the older institution (founded 1785); the other (founded 2014) has shaped its medical school around modern integrated-curriculum thinking.

Side-by-side comparison

Barts and The London (Queen Mary)

London

Quick comparison

Location
London, UK
A-Level offer
A*AA at A-level achieved in one sitting over a study period of no longer than two years
TrueScore
2010
UCAT home cut-off
~2000+ /2700 (A100 Home; 2025 entry cut-off ≈ 2003 /2700)
Interview format
Multiple Mini Interviews (MMI)
Post-interview chance
UK Undergrad: 948/1294 = 73% (2025); International: 61/159 = 38%; A101 Graduate Medicine: 55/127 = 43%
Decision date
March onwards

University of Central Lancashire (UCLan)

Preston

Quick comparison

Location
Preston, UK
A-Level offer
AAB at A-level including Biology and Chemistry (home applicants)
TrueScore
-
UCAT home cut-off
UCAT used for home applicant shortlisting; no published cut-off
Interview format
Multiple Mini Interviews (MMI)
Post-interview chance
-
Decision date
March - April
Compare different schools

Barts and The London (Queen Mary) vs University of Central Lancashire (UCLan) - in detail

A-Level and academic profile

Barts and The London (Queen Mary) requires A*AA including Chemistry and Biology/Physics/Mathematics. University of Central Lancashire (UCLan) requires AAB at A-level including Biology and Chemistry (home applicants). Barts and The London (Queen Mary) is the stricter A-Level offer; University of Central Lancashire (UCLan) is slightly more forgiving. If your predicted grades are borderline, University of Central Lancashire (UCLan) carries the lower academic-rejection risk pre-interview.

Interview formats

Both Barts and The London (Queen Mary) and University of Central Lancashire (UCLan) use MMI interviews, so the underlying prep approach is the same — practise ethics frameworks, NHS hot-topic answers and (for MMI) structured station responses against a timer. Interview windows: Barts and The London (Queen Mary) interviews in December - February; University of Central Lancashire (UCLan) in December - February.

What makes each distinctive

Barts and The London (Queen Mary): No longer 50:50 weighted on A-level predictions and UCAT - anyone who exceeds the UCAT cut-off generally gets an interview regardless of predictions. SJT band adds bonus points to interview score post-interview (Band 1 = +2, Band 2 = +1, Band 3 = 0). University of Central Lancashire (UCLan): One of the first UK universities to run a privately-funded medical school open to international students; substantial international cohort blended with a smaller home intake. Strong Lancashire regional placement network.

Which is right for you?

For applicants with predicted A-Level grades at the lower end of the AAA-A*AA range, University of Central Lancashire (UCLan) is the lower-risk academic option. Regionally, the choice often comes down to cost of living and NHS-deanery preferences — Barts and The London (Queen Mary) feeds into the London foundation programme network; University of Central Lancashire (UCLan) into the England network. Your firm/insurance choice should ultimately weight: where your UCAT and predicted grades sit relative to each school's threshold, which interview format you can prepare for most credibly, and where you'd actually want to live for five or six years.

Common questions

School data reviewed by the NextGen MedPrep editorial team — last reviewed 3 July 2026.